Clinical trial
Pharmacokinetics of Inhaled Levosimendan
NCT06387862 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetics of Inhaled Levosimendan
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- February 1, 2024
- Completion date
- January 31, 2025
- Enrollment
- 6 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
left ventricular dysfunction